In our cohort, we observed a high level of TP53 mutations in high-CIN patients, while PIK3CA alterations were significantly enriched in low-CIN patients, with a tendency for mutual exclusivity with TP53 mutations. The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.